These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28635110)

  • 1. Applied botulinum neurotoxin injection in a patient with dementia to reduce hypersalivation.
    Yuruyen M; Gokturk A; Yavuzer H; Döventas A; Erdincler DS
    Geriatr Gerontol Int; 2017 Jun; 17(6):1028-1029. PubMed ID: 28635110
    [No Abstract]   [Full Text] [Related]  

  • 2. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?
    Vaile L; Finlay F
    Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders].
    García Ron A; Miranda MC; Garriga Braun C; Jensen Verón J; Torrens Martinez J; Diez Hanbino MP
    An Pediatr (Barc); 2012 Oct; 77(4):289-91. PubMed ID: 22652186
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
    Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
    J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
    [No Abstract]   [Full Text] [Related]  

  • 5. Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A.
    Tiigimäe-Saar J; Tamme T; Rosenthal M; Kadastik-Eerme L; Taba P
    Neurol Sci; 2018 May; 39(5):871-877. PubMed ID: 29460161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
    Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?
    Tiigimäe-Saar J; Taba P; Tamme T
    Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin A after microvascular ALT flap in a patient with (corrected) squamous cell carcinoma of the tongue].
    Ihler F; Laskawi R; Matthias C; Rustenbeck HH; Canis M
    HNO; 2012 Jun; 60(6):524-7. PubMed ID: 22534678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of botulinum toxin A for treatment of drooling.
    Lipp A; Trottenberg T; Schink T; Kupsch A; Arnold G
    Neurology; 2003 Nov; 61(9):1279-81. PubMed ID: 14610139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incobotulinumtoxin A for Sialorrhea in Neurological Disorders: A Real-Life Experience.
    Martínez-Poles J; Nedkova-Hristova V; Escribano-Paredes JB; García-Madrona S; Natera-Villalba E; Estévez-Fraga C; López-Sendón Moreno JL; Avilés-Olmos I; Sánchez Díaz G; Martínez Castrillo JC; Alonso-Canovas A
    Toxins (Basel); 2018 May; 10(6):. PubMed ID: 29843420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of drooling: 10 years after the Consortium on Drooling 1990.
    Berweck S; Schwerin A; Heinen F
    Dev Med Child Neurol; 2003 Dec; 45(12):845; author reply 845-6. PubMed ID: 14667080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with botulinum toxin in neurologic pediatrics].
    Justus N; Lee SH; Berweck S; Heinen F
    Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin for treatment of parkinsonian sialorrhea.
    Friedman A; Potulska A
    Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin in the Management of Sialorrhoea in Acquired Brain Injury.
    Carrol A; McGlone B
    Ir Med J; 2016 Jun; 109(6):425. PubMed ID: 27814442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
    Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
    Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology.
    Braun T; Gürkov R; Hempel JM; Berghaus A; Krause E
    Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1963-7. PubMed ID: 20563590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability.
    Bekkers S; Leow TY; Van Hulst K; Orriëns LB; Scheffer AR; Van Den Hoogen FJ
    Dev Med Child Neurol; 2021 Aug; 63(8):991-997. PubMed ID: 33772779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review.
    Oliveira AF; Silva GA; Almeida DM
    Einstein (Sao Paulo); 2016; 14(3):431-434. PubMed ID: 27759834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.